Evidence map›Paper›PMID 28915830›Full record

ArticleJournal of ovarian research2017

Biological effects of combined resveratrol and vitamin D3 on ovarian tissue.

Francesca Uberti, Vera Morsanuto, Silvio Aprile, Sabrina Ghirlanda, Ian Stoppa, Andrea Cochis, Giorgio Grosa, Lia Rimondini, Claudio Molinari

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04841499 (Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause), which is not on this map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04841499 nacompletednot on this mapstarted 2021, after this paper: background citation

Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause

TypeinterventionalSponsorUniversity of South AlabamaRan2021 to 2021Enrolled40ConditionsMenopauseArmsBASIS™ (Crystalline Nicotinamide Riboside 250mg and Pterostilbene 50mg)
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Potential Adverse Effects of Resveratrol: A Literature Review.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Francesca UbertiPhysiology Laboratory, Department of Translational Medicine, UPO, Via Solaroli, 17 28100, Novara, Italy. francesca.uberti@med.uniupo.it.
Vera MorsanutoPhysiology Laboratory, Department of Translational Medicine, UPO, Via Solaroli, 17 28100, Novara, Italy.
Silvio AprileDepartment of Pharmaceutical Sciences and Drug and Food Biotechnology Center, UPO, Novara, Italy.
Sabrina GhirlandaPhysiology Laboratory, Department of Translational Medicine, UPO, Via Solaroli, 17 28100, Novara, Italy.
Ian StoppaPhysiology Laboratory, Department of Translational Medicine, UPO, Via Solaroli, 17 28100, Novara, Italy.
Andrea CochisDepartment of Health Sciences, Medical School, UPO, Novara, Italy.
Giorgio GrosaDepartment of Pharmaceutical Sciences and Drug and Food Biotechnology Center, UPO, Novara, Italy.
Lia RimondiniDepartment of Health Sciences, Medical School, UPO, Novara, Italy.
Claudio MolinariPhysiology Laboratory, Department of Translational Medicine, UPO, Via Solaroli, 17 28100, Novara, Italy.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResveratrol (3,5,4'-trihydroxy-trans-stilbene) is a natural antioxidant polyphenol able to exert a wide range of biological effect on several tissues. Despite its important beneficial properties, it has a low water solubility, which limits its therapeutic applications in humans. Resveratrol also acts as a phytoestrogen that modulates estrogen receptor (ER)-mediated transcription. In addition, it has been shown that ovarian tissues benefit greatly from vitamin D3, which exerts its beneficial effects through VDR receptors. The aim was to evaluate the cooperative effects of resveratrol combined with vitamin D3 on ovarian cells and tissues and some other organs as well. Moreover, the modulation of specific intracellular pathways involving ER and VDR receptors has been studied.

methodsThe experiments were performed both in vitro and in vivo, to analyze cell viability, radical oxygen species production, signal transductions through Western Blot, and resveratrol quantification by HPLC.

resultsCell viability, radical oxygen species production, and intracellular pathways have been studied on CHO-K1 cells. Also, the relative mechanism activated following oral intake in female Wistar rats as animal model was investigated, evaluating bioavailability, biodistribution and signal transduction in heart, kidney, liver and ovarian tissues. Both in in vitro and in vivo experiments, resveratrol exerts more evident effects when administered in combination with vitD in ovarian cells, showing a common biphasic cooperative effect: The role of vitamin D3 in maintaining and supporting the biological activity of resveratrol has been clearly observed. Moreover, resveratrol plus vitamin D3 blood concentrations showed a biphasic absorption rate.

conclusionsSuch results could be used as a fundamental data for the development of new therapies for gynecological conditions, such as hot-flashes.

Indexed as

AnimalsAntioxidantsBiological AvailabilityCell SurvivalCHO CellsCholecalciferolCricetulusDrug InteractionsExtracellular Signal-Regulated MAP KinasesFemaleOvaryProto-Oncogene Proteins c-aktRats, WistarReactive Oxygen SpeciesResveratrolStilbenesAntioxidantsCholecalciferolExtracellular Signal-Regulated MAP KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesResveratrolStilbenesSuperoxide DismutaseBioavailabilityHot flashesPhytoalexinsResveratrolVitamin D3

Identifiers

PMID28915830
PMCPMC5602920
OpenAlexW2755363667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.